Comparison of Two Gait Re-training Modalities During a Cardiac Rehabilitation Stay: Benefit of Orienteering Walking

NCT ID: NCT06941597

Last Updated: 2025-12-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-04-28

Study Completion Date

2025-10-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cardiovascular disease (CVD) is the leading cause of death in France for women and the second leading cause of death for men after cancer. They cause around 140,000 deaths every year, or almost 400 people every day throughout France. CVD also accounts for over a million hospital admissions a year, 160,000 of which are attributable to heart failure.

At present, cardiovascular rehabilitation centres mainly use exercise training methods based on sessions on cycloergometers and active walking (walking on a track and/or treadmill). Convinced of the added value of Orienteering, we have included it in our routine treatment as part of our Cardiac Rehabilitation programme, in addition to sessions on cycloergometers and active walking since 2021. As there is little literature on the subject in our population of interest, the aim of this study is to provide evidence of the relevance of orienteering in the cardiac rehabilitation programme.

We hypothesise that orienteering induces a similar cardiac response, amount of physical activity and perception of symptoms compared with an active walking session, while providing greater enjoyment of the activity.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiovascular Diseases (CVD) Coronary Heart Disease (CHD) Heart Failure Congenital Heart Disease

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

cardiovascular diseases cardiac rehabilitation active walking orienteering heart rate

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

cardiac rehabilitation group

The management of patients included in this study is unchanged from that usually recommended. The patients included in the study will undergo the same rehabilitation sessions during their stay as patients coming to the centre as a matter of routine. In total, 3 sessions of active walking, 3 sessions of orienteering and 7 sessions of ergocycles were carried out during the stay. The cardiac rehabilitation programme lasted 3 weeks, and all the sessions evaluated as part of the study (active walking, orienteering and ergocycles) were carried out during the last two weeks of the rehabilitation course. For each activity (active walking and orienteering), a familiarisation session will be carried out before the session evaluated as part of the study. The order in which the orientation walking and active walking sessions are carried out will depend on the weeks in which the subjects are included, and may vary according to the organisation of the centre.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with stabilised heart disease, coronary artery disease, heart failure, post-operative stay after cardiac surgery, congenital heart disease, patients at high cardiovascular risk and obliterative arteritis of the lower limbs;
* Who have been informed and do not object to the study;
* Over 18 years of age;
* Participating in a cardiac rehabilitation programme;
* With a walking distance of less than 3,600 metres;
* Able to understand and comply with the requirements of the protocol.

Exclusion Criteria

* Pregnant or breast-feeding women
* Persons under guardianship or trusteeship
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Univ Brest, Laboratory ORPHY, F-29200 Brest, France

UNKNOWN

Sponsor Role collaborator

Fondation Ildys

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Klervie BAILLY

Role: PRINCIPAL_INVESTIGATOR

Fondation Ildys

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fondation ILDYS, Site de Ty Yann

Brest, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RI2024_018

Identifier Type: -

Identifier Source: org_study_id